EGRX - Eagle Pharmaceuticals Non-GAAP EPS of $1.18 beats by $0.04 revenue of $64.6M beats by $5.24M
2023-08-08 06:54:55 ET
- Eagle Pharmaceuticals press release ( NASDAQ: EGRX ): Q2 Non-GAAP EPS of $1.18 beats by $0.04 .
- Revenue of $64.6M (-12.8% Y/Y) beats by $5.24M .
For further details see:
Eagle Pharmaceuticals Non-GAAP EPS of $1.18 beats by $0.04, revenue of $64.6M beats by $5.24M